Galectin Therapeutics Inc. · NASDAQ:GALT
Jamil Khurram sold 16,250 Galectin Therapeutics Inc. shares (Form 4)
Traded Jul 14, 2026 · Filed Jul 16, 2026
On Jul 14, 2026, Jamil Khurram (Chief Medical Officer) sold 16,250 Galectin Therapeutics Inc. shares at US$5.13 for US$83,363 under a trading plan, leaving 0 shares. Filed Jul 16, 2026 (Form 4).
- Sold
- 16,250 shares
- Price
- US$5.13
- Value
- US$83,363
- Holding after
- 0 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 14, 2026 | Common Stock | Option exercise | 16,250 | US$3.04 | 16,250 | Direct |
| Jul 14, 2026 | Common Stock | Sale | 16,250 | US$5.13 | 0 | Direct |
Source
Related
- Galectin Therapeutics Inc.
- Jamil Khurram
- Galectin Therapeutics Inc. shareholders
- Form 4 · Jamil Khurram · Jun 30, 2026
- Form 4 · Jamil Khurram · Jun 25, 2026
- Form 4 · Jamil Khurram · May 28, 2026
- Form 4 · Richard E. Uihlein · Aug 4, 2026
- Schedule 13D/A · Richard E. Uihlein · Aug 4, 2026
- Form 4 · Shlevin Harold H. · Jun 30, 2026